Trial Profile
Retrospective study evaluating the response of postmenopausal osteoporosis subjects treated with denosumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 13 Feb 2016 New trial record